Dongchen Zhou

机构：Ministry of Education of the People's Republic of China, National Clinical Research Center for Digestive Diseases, National Clinical Research, First Affiliated Hospital Zhejiang University, Huazhong University of Science and Technology · ORCID：0000-0003-1923-9671

发表论文 73 篇 · 总被引 751 次 · h-index 13

代表论文

• Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors (2024 · Cell · 被引 101)
• Phosphorylated IRF3 promotes GSDME-mediated pyroptosis through RIPK1/FADD/caspase-8 complex formation during mitotic arrest in ovarian cancer (2025 · Cell Communication and Signaling · 被引 11)
• A pan-cancer single-cell analysis reveals the effect of PD-1 blockades on tumor angiogenesis by inhibiting the endothelial CXCL12-CXCR4 axis (2025 · Cancer Immunology Immunotherapy · 被引 6)
• PARP inhibitors accumulate B7-H3 on fibroblasts via blocking autophagic flux to potentiate immune evasion in ovarian cancer (2025 · OncoImmunology · 被引 5)
• Miniature Mass Spectrometry for Point-of-Care Testing the GPIIb/IIIa Inhibitor Tirofiban during Perioperative Period of Percutaneous Coronary Intervention (2024 · ACS Omega · 被引 5)
• Clinical outcomes of radiofrequency catheter ablation guided by intracardiac echocardiography for Chinese atrial fibrillation patients: a single-center, retrospective study (2024 · Journal of Thoracic Disease · 被引 3)